A weekly compounded tirzepatide protocol. The dual GLP-1 and GIP regimen, reviewed and prescribed by US-licensed physicians when clinically appropriate.
First 50 rate, locked for life. No price increases as your dose goes up.
Reserve your spotToday's $149 reserves your First 50 membership and locks the $160/mo rate. Treatment is prescribed and billed separately, only when clinically appropriate.
Compounded tirzepatide is not FDA-approved. The FDA does not evaluate compounded drugs for safety, effectiveness, or quality. A licensed provider must determine if this treatment is clinically appropriate for you. Do not use if pregnant, planning pregnancy, or breastfeeding. Individual results will vary. This is not a guarantee of weight loss.
Answer questions about your health history, current medications, and goals. Takes under 5 minutes. No video call. No waiting room. 100% HIPAA-secure.
A board-certified clinician reviews your intake within 48 hours and determines if compounded tirzepatide is clinically appropriate for you. Not a chatbot. Not an algorithm.
If approved, your prescription is filled by a licensed 503A compounding pharmacy and shipped in discreet packaging within 3 to 5 business days. Free every month.
Tirzepatide is a once-weekly GLP-1 and GIP receptor agonist. It helps regulate appetite and how your body responds to food, while your provider tailors the dose to you over time.
No. Compounded tirzepatide is not FDA-approved as a finished drug product. The FDA does not evaluate compounded medications for safety, effectiveness, or quality the way it does brand-name drugs. It is legally prepared by a licensed 503A compounding pharmacy and prescribed by a licensed provider. If safety is your primary concern, FDA-approved tirzepatide products are the more conservative option.
Brand-name tirzepatide is FDA-approved and made by its original drug maker. Compounded tirzepatide contains the same active ingredient but is prepared by a licensed compounding pharmacy and is not FDA-approved as a finished product. Both require a prescription from a licensed provider.
Individual results vary significantly and are not guaranteed. Some patients notice reduced appetite within the first few weeks. Weight changes depend on your dose, adherence, and lifestyle. Compounded medications have not been independently studied, and your provider will set expectations for your situation.
The most common side effects are GI-related: nausea, diarrhea, constipation, or vomiting, especially during the first weeks of treatment. These typically ease as your body adjusts. Serious but rare risks include pancreatitis, gallbladder problems, and a potential increased risk of thyroid tumors. Do not use if you have a personal or family history of medullary thyroid carcinoma or MEN2. Your provider will review your complete health history before prescribing.
Yes. No contracts and no cancellation fees. Cancel anytime through your patient portal or by messaging our support team. Your current month’s shipment will always be sent before any cancellation takes effect.
Free intake. Licensed provider review. Ships if approved.
Reserve your spotFirst 50 presale. Fully refundable any time before your first physician consultation.
The First 50 is opening soon. Reserve your spot below and we'll notify you the moment payment opens.
Notify me when it opens